Literature DB >> 7542152

Rationale for the use of alpha-blockers in the treatment of benign prostatic hyperplasia (BPH).

K Kawabe1, N Moriyama, S Yamada, N Taniguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7542152     DOI： 10.1111/j.1442-2042.1994.tb00036.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  5 in total

1.  Thermoanalytical investigation of terazosin hydrochloride.

Authors:  Ali Kamal Attia; Mona Mohamed Abdel-Moety
Journal:  Adv Pharm Bull       Date:  2013-02-07

Review 2.  α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

Authors:  Shizuo Yamada; Yoshihiko Ito; Hideo Tsukada
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

3.  Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue.

Authors:  K Nasu; N Moriyama; K Kawabe; G Tsujimoto; M Murai; T Tanaka; J Yano
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Detection of alpha 1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization.

Authors:  N Moriyama; S Kurimoto; S Horie; K Nasu; T Tanaka; K Yano; H Hirano; G Tsujimoto; K Kawabe
Journal:  Histochem J       Date:  1996-04

5.  Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.

Authors:  Aneta Doricakova; Dirk Theile; Johanna Weiss; Radim Vrzal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-27       Impact factor: 3.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.